未登录

P

Poyil Pratheeshkumar

University of Kentucky

H指数:34

被引数:3,589

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The co-targeting of PLK1 and FoxM1 contributes to synergistic antitumor effects in PTC

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Furin predicts prognosis and promotes PTC progression and metastasis via MEK-ERK axis

CANCER RESEARCH

IF16.6

2023-04-040

PRE

KLF5 and its association with HIF-1α promotes PTC progression and metastatic potential through AKT activation

CANCER RESEARCH

IF16.6

2020-08-150

PRE

RETRACTION: Ethanol Enhances Tumor Angiogenesis In Vitro Induced by Low-Dose Arsenic in Colon Cancer Cells Through Hypoxia-Inducible Factor 1 Alpha Pathway (Retraction of Vol 130, Pg 269, 2012)

TOXICOLOGICAL SCIENCES

IF4.1

2020-02-280

OAAI

APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2020-01-0114

OAAI

RETRACTION: Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism (Retraction Article) (Retraction of Vol 6, art no 37227, 2016)

SCIENTIFIC REPORTS

IF3.9

2019-11-150

OAAI

RETRACTION: Activation of epidermal growth factor receptor/p38/hypoxia-inducible factor-1 α is pivotal for angiogenesis and tumorigenesis of malignantly transformed cells induced by hexavalent chromium. (Retraction Article, vol 291, pg 16271, 2016) (Retraction of Vol 291, Pg 16271, 2016)

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2019-10-010

OAAI

Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma

EUROPEAN JOURNAL OF CANCER

IF7.1

2019-08-0116

PREAI

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment

CANCER RESEARCH

IF16.6

2019-07-010

PRE

TGFβ induced SMAD4 dependent apoptosis proceeded by EMT in colorectal cancer

CANCER RESEARCH

IF16.6

2019-07-010

PRE

TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC

MOLECULAR CANCER THERAPEUTICS

IF5.5

2019-07-0122

OAAI

RETRACTION: Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis (Retraction of Vol 289, Pg 28660, 2014)

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2018-10-011

OAAI

RETRACTION: Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells. (Retraction of Vol 292, Pg 8315, 2017)

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2018-10-011

OAAI

RETRACTION: Antioncogenic and oncogenic properties of Nrf2 in arsenic-induced carcinogenesis. (Retraction of Vol 290, Pg 27090, 2015)

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2018-10-010

OAAI

Roles of ROS, Nrf2, and autophagy in cadmium-carcinogenesis and its prevention by sulforaphane

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2018-08-01125

OAAI

Downregulation of SKP2 in Papillary Thyroid Cancer Acts Synergistically With TRAIL on Inducing Apoptosis via ROS

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2017-12-2813

OAAI

XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis

IF3.4

2017-09-1140

OAAI

Protection from Cr(VI)-induced malignant cell transformation and tumorigenesis of Cr(VI)-transformed cells by luteolin through Nrf2 signaling

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2017-09-0121

OAAI

Inhibition of papillary thyroid cancer cells progression by targeting skp2 via ros-erk-chop-dr5 pathways

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Sorafenib and FH535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function

DIGESTIVE AND LIVER DISEASE

IF3.8

2017-06-0125

PREAI